Publications by authors named "Yuehong Cui"

Claim this Profile
T
The effective molecular characteristics of PD-1 inhibitor combination regimen as the first-line treatment for Chinese patients with HER2-positive gastric cancer: a real-world retrospective analysis study.
Lingyun Zhang, Bin Guan, Wei Li, Shan Yu, Qian Li, Yuehong Cui

Transl Gastroenterol Hepatol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Uncovering the genetic variation spectrum of colorectal polyposis from a multicentre cohort in China.
Mengyuan Yang, Ding Zhang, Zhijun Yuan, Daici Chen, Haixing Ju, Yuehong Cui

NPJ Precis Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transarterial Infusion Chemotherapy and Embolization for Patients With Unresectable Advanced Cancer of Stomach or Gastroesophageal Junction: A Retrospective Study.
Lingqiang Min, Zheng Liu, Bo Zhou, Peng Zhou, Rongkui Luo, Yuehong Cui

Cancer Med· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nivolumab plus anlotinib hydrochloride in advanced gastric adenocarcinoma and esophageal squamous cell carcinoma: the phase II OASIS trial.
Jing Wu, Shilong Zhang, Shan Yu, Guo An, Yi Wang, Yuehong Cui

Nat Commun· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tislelizumab plus cetuximab and irinotecan in refractory microsatellite stable and RAS wild-type metastatic colorectal cancer: a single-arm phase 2 study.
Xiaojing Xu, Luoyan Ai, Keshu Hu, Li Liang, Minzhi Lv, Yuehong Cui

Nat Commun· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and validation of an individualized nomogram for gastric cancer patients treated with perioperative chemotherapy followed by radical surgery.
Yan Wang, Shilong Zhang, Bowen Ding, Zhaoqing Tang, Yuan Ji, Yuehong Cui

Transl Gastroenterol Hepatol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Pyrotinib With/Without Trastuzumab in Treatment-Refractory, HER2-Positive Metastatic Colorectal Cancer: Result From a Prospective Observational Study.
Haojie Zhou, Minzhi Lv, Wei Li, Yan Wang, Jing Wu, Yuehong Cui

Clin Colorectal Cancer· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Benefit of Avapritinib in KIT-Mutant Gastrointestinal Stromal Tumors: A Post Hoc Analysis of the Phase I NAVIGATOR and Phase I/II CS3007-001 Studies.
Michael C Heinrich, Xinhua Zhang, Robin L Jones, Suzanne George, César Serrano, Yuehong Cui

Clin Cancer Res· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical significance of peripheral T-cell receptor repertoire profiling and individualized nomograms in patients with gastrointestinal cancer treated with anti-programmed death 1 antibody.
Jing Wu, Yiyi Yu, Shilong Zhang, Pengfei Zhang, Shan Yu, Yuehong Cui

Transl Gastroenterol Hepatol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coiled-coil domain-containing 154 promotes colorectal cancer proliferation and metastasis via interacting with minichromosome maintenance complex component 2.
Wei-Feng Hong, De-Xiang Zhu, Yan-Jie Chen, Xi-Zhong Shen, Yue-Hong Cui

Cancer Lett· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer stem cell-derived exosome-induced metastatic cancer: An orchestra within the tumor microenvironment.
Khalid Rashid, Aqeel Ahmad, Semmal Syed Meerasa, Abdul Q Khan, Xiaobo Wu, Yuehong Cui

Biochimie· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preoperative chemotherapy prior to primary tumour resection for asymptomatic synchronous unresectable colorectal liver-limited metastases: The RECUT multicenter randomised controlled trial.
Qi Lin, Kefeng Ding, Ren Zhao, Hao Wang, Ye Wei, Yuehong Cui

Eur J Cancer· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nestin overexpression reduces the sensitivity of gastric cancer cells to trastuzumab.
Yi-Chou Wei, Jiang-Yi Zhu, Jing Wu, Shan Yu, Wei Li, Yue-Hong Cui

J Gastrointest Oncol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does resection after neoadjuvant chemotherapy of docetaxel, oxaliplatin, and S-1 (DOS regimen) benefit for gastric cancer patients with single non-curable factor? a multicenter, prospective cohort study (Neo-REGATTA).
Yuehong Cui, Yiyi Yu, Song Zheng, Jie'er Ying, Yi'an Du

BMC Cancer· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identifying HER2 from serum-derived exosomes in advanced gastric cancer as a promising biomarker for assessing tissue HER2 status and predicting the efficacy of trastuzumab-based therapy.
Qian Li, Minzhi Lv, Lihua Lv, Nida Cao, Aiguang Zhao, Yuehong Cui

Cancer Med· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Avapritinib in Treating Unresectable or Metastatic Gastrointestinal Stromal Tumors: A Phase I/II, Open-Label, Multicenter Study.
Jian Li, Xinhua Zhang, Yanhong Deng, Xin Wu, Zhichao Zheng, Yuehong Cui

Oncologist· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiplex immune profiling reveals the role of serum immune proteomics in predicting response to preoperative chemotherapy of gastric cancer.
Zhaoqing Tang, Yuan Gu, Zhongyi Shi, Lingqiang Min, Ziwei Zhang, Yuehong Cui

Cell Rep Med· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I study of adjuvant chemotherapy with nab-paclitaxel and S-1 for stage III Lauren's diffuse-type gastric cancer after D2 resection (NORDICA study).
Yuehong Cui, Yiyi Yu, Shan Yu, Wei Li, Yan Wang

Cancer Med· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interaction between glycolysis‒cholesterol synthesis axis and tumor microenvironment reveal that gamma-glutamyl hydrolase suppresses glycolysis in colon cancer.
Yan-Jie Chen, Xi Guo, Meng-Ling Liu, Yi-Yi Yu, Yue-Hong Cui

Front Immunol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Neo-PLANET phase II trial of neoadjuvant camrelizumab plus concurrent chemoradiotherapy in locally advanced adenocarcinoma of stomach or gastroesophageal junction.
Zhaoqing Tang, Yan Wang, Dan Liu, Xuefei Wang, Chen Xu, Yuehong Cui

Nat Commun· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic profiling and the impact of MUC19 mutation in hepatoid adenocarcinoma of the stomach.
Mengxuan Zhu, Erbao Chen, Shan Yu, Chen Xu, Yiyi Yu, Yuehong Cui

Cancer Commun (Lond)· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toripalimab in advanced biliary tract cancer.
Wei Li, Yueqi Wang, Yiyi Yu, Qian Li, Yan Wang, Yuehong Cui

Innovation (Camb)· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of AS versus SOX regimen as first-line chemotherapy for gastric cancer patients with peritoneal metastasis: a real-world study.
Lingyun Zhang, Jiayu Zhang, Yan Wang, Wei Li, Shan Yu, Yuehong Cui

BMC Gastroenterol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant apatinib combined with oxaliplatin and capecitabine in patients with locally advanced adenocarcinoma of stomach or gastroesophageal junction: a single-arm, open-label, phase 2 trial.
Zhaoqing Tang, Yan Wang, Yiyi Yu, Yuehong Cui, Liang Liang

BMC Med· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An integrated bioinformatic investigation of mitochondrial solute carrier family 25 (SLC25) in colon cancer followed by preliminary validation of member 5 (SLC25A5) in tumorigenesis.
Yan-Jie Chen, Wei-Feng Hong, Meng-Ling Liu, Xi Guo, Yi-Yi Yu, Yue-Hong Cui

Cell Death Dis· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis